Estimate of the number of patients eligible for treatment with drotrecogin alfa (activated) based on differing international indications: Post-hoc analysis of an inception cohort study in Australia and New Zealand
The ANZICS Clinical Trials Group Sepsis Investigators
Research output: Contribution to journal › Article › peer-review
1Citation
(Scopus)
Fingerprint
Dive into the research topics of 'Estimate of the number of patients eligible for treatment with drotrecogin alfa (activated) based on differing international indications: Post-hoc analysis of an inception cohort study in Australia and New Zealand'. Together they form a unique fingerprint.